Zgnx: very good DD. according to company website , if you go through the presentation in investor section , it says 261 million for zohydro and 66 million for their commercial product , migraine injection.
Am I missing something . I think phase three data will be good .
Analyst who do the offering always inflate the price, don't get me wrong . I am saying this as I have got burned severely by doing this in past . Good luck to you. Will definitely look in to it second half of 2012
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.